Joon-Seo Park
Comptroller/Controller/Auditor bei NC& CO.,LTD
Profil
Joon-Seo Park is currently working as an Auditor at NC & Co., Ltd., Han Kyung Accounting Corp., Biobud Ltd., and Nconnect Corp.
He has a graduate degree from Seoul National University and an undergraduate degree from Sogang University.
Aktive Positionen von Joon-Seo Park
| Unternehmen | Position | Beginn |
|---|---|---|
| NC& CO.,LTD | Comptroller/Controller/Auditor | - |
Han Kyung Accounting Corp.
 Han Kyung Accounting Corp. Miscellaneous Commercial ServicesCommercial Services Han Kyung Accounting Corp. provides accounting, payroll, auditing, and tax consulting services. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Jae-Seon Hong. | Corporate Officer/Principal | 30.09.2012 |
| Nconnect Corp. | Comptroller/Controller/Auditor | - |
Biobud Ltd.
 Biobud Ltd. Medical SpecialtiesHealth Technology Biobud Ltd. engages in the development of biopharmaceuticals for cardiovascular prevention, diagnosis and treatment. The company was founded on March 28, 2000, and is headquartered in Seongnam, South Korea. | Comptroller/Controller/Auditor | - |
Ausbildung von Joon-Seo Park
| Seoul National University | Graduate Degree |
| Sogang University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NC& CO.,LTD | Electronic Technology |
| Private Unternehmen | 3 |
|---|---|
Han Kyung Accounting Corp.
Han Kyung Accounting Corp. Miscellaneous Commercial ServicesCommercial Services Han Kyung Accounting Corp. provides accounting, payroll, auditing, and tax consulting services. The private company is based in Seoul, South Korea. The CEO of the South Korean company is Jae-Seon Hong. | Commercial Services |
Biobud Ltd.
Biobud Ltd. Medical SpecialtiesHealth Technology Biobud Ltd. engages in the development of biopharmaceuticals for cardiovascular prevention, diagnosis and treatment. The company was founded on March 28, 2000, and is headquartered in Seongnam, South Korea. | Health Technology |
| Nconnect Corp. |
